GALT
#3199
Galectin Therapeutics Inc. - Common Stock
5.3 4 USD
+0.16%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+16.09%
Monthly Change
+103.82%
6 month change
+73.38%
Year Change
+90.71%
Previous Close
4.6 0
Open
5.3 4
Low
5.3 4
High
5.3 4
Volume
48
Financials
- Market Capitalization 351.68 M
- Employee 9
- Founded 2000
- CEO N/A
- Website www.galectintherapeutics.com
- Headquarter Nevada, United States
- FIGI BBG000BK6FP5
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-8.67
Price to sales ratio
-74.93
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3174 |  LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.62 USD | -0.65% | -3.95% | -2.12% | +11.06% | 362.77 M USD | ||
| 3196 |  VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.85 USD | -2.50% | -8.59% | -0.51% | +5.79% | 351.79 M USD | ||
| 3206 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 4.39 USD | -1.13% | -11.49% | +0.46% | +441.98% | 349.64 M USD | ||
| 3210 |  FATE Fate Therapeutics, Inc. - Common Stock | 2.99 USD | -0.99% | +2.40% | +47.29% | +162.28% | 348.51 M USD |
Frequently asked questions about Galectin Therapeutics Inc. - Common Stock
What is the Galectin Therapeutics Inc. - Common Stock stock price today?
The current price of Galectin Therapeutics Inc. - Common Stock (GALT) is 5.34. Over the past 24 hours, the stock has changed by +16.09%. Follow the GALT chart for real-time price dynamics.
What is the stock ticker of Galectin Therapeutics Inc. - Common Stock?
Galectin Therapeutics Inc. - Common Stock trades under the ticker GALT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Galectin Therapeutics Inc. - Common Stock stock going up?
GALT has changed by +18.40% over the last week, +103.82% over the last month, and +90.71% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Galectin Therapeutics Inc. - Common Stock net income for the last quarter?
Galectin Therapeutics Inc. - Common Stock reported net income of -5.05 M for the last quarter. The previous quarter showed -5.5 M, which means net income changed by +8.25%.
How many employees does Galectin Therapeutics Inc. - Common Stock have?
As of the latest available data, Galectin Therapeutics Inc. - Common Stock has 9 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Galectin Therapeutics Inc. - Common Stock stock?
You can buy Galectin Therapeutics Inc. - Common Stock (GALT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Galectin Therapeutics Inc. - Common Stock stock?
Investing in Galectin Therapeutics Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GALT chart and related analysis on metatrader.com as part of your research.